Company Announcements

New Shares issued pursuant to Scrip Dividend, TVR

Source: RNS
RNS Number : 3230P
Manx Financial Group PLC
17 June 2022
 

FOR IMMEDIATE RELEASE                                            17 June 2022

 

 

Manx Financial Group PLC (the "Group")

 

Issue of Ordinary Shares pursuant to the Scrip Dividend

and Total Voting Rights

 

Further to the announcement made on 25th May 2022 in relation to the Scrip Dividend, the Group announces that it has received valid elections from shareholders resulting in a requirement to issue 513,145 New Ordinary Shares ("New Shares") at a price of 8.025 pence per share.

 

In addition, Jim Mellon and Dr Gregory Bailey, both Directors and significant shareholders of the Group, will be issued 146,664 and 121,540 Ordinary Shares of no par value ("Ordinary Shares") respectively at a price of 8.025 pence per share representing their partial Script Dividend entitlements, thus maintaining their joint percentage holding under the Concert Party whitewash waiver approved on 9th April 2020. Douglas Grant and Alan Clarke, also Directors of the Group, have elected to receive Ordinary Shares under the Scrip Dividend as further set out in the table below.

 

Application has been made for the total of 781,349 New Shares to satisfy the Scrip Dividend exercise, which will rank pari passu with all existing Ordinary Shares, to be admitted to trading on AIM. Admission is expected on or around 23rd June 2022.

 

Following the issue of the New Shares and Additional Allotment, the Company's issued share capital consists of 115,072,988 Ordinary Shares of no-par value, with voting rights ("Ordinary Shares"). The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights is 115,072,988.

 

Directors' Dealings

 

The respective holdings of the Directors following the issue of ordinary shares pursuant to the Scrip Dividend:

 


Scrip Shares Issued

Total number of shares held

% of Issued Capital

Jim Mellon 1

146,664

21,669,314

18.83

Gregory Bailey 2

121,540

17,957,290

15.61

Douglas Grant

15,774

533,951

0.46

Alan Clarke

1,626

55,048

0.05

 

1     Burnbrae Limited holds 19,341,332 Ordinary Shares. Burnbrae Limited is 100% beneficially owned by Jim Mellon. Denham Eke, Executive Vice-Chairman of MFG, is also a director of Burnbrae Limited. Vidacos Nominees Limited also holds 2,327,982 Ordinary Shares in trust for Jim Mellon

2     Vidacos Nominees Limited holds 17,957,290 Ordinary Shares in trust for Gregory Bailey.

 

Total Voting Rights

 

The figure of 115,072,988 Ordinary Shares may be used by shareholders in the Group from the date of admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the shares of the Group under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

 

For further information, please contact:

 

Manx Financial Group PLC

Denham Eke,

Executive Vice Chairman

Tel +44 (0)1624 694694

Beaumont Cornish Limited

Roland Cornish/James Biddle

Tel +44 (0) 20 7628 3396

Greentarget Limited

Dafina Grapci-Penney

Tel +44 (0) 203 963 1887

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAFKXFDNAEFA